Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,2613,280 of 20,252 grants

Active NON-SBIR/STTR RPGS
Small-molecule degraders of STAT5
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2028

Abstract Transducer and Activator of Transcription 5 (STAT5) is a transcriptional factor and has been proposed as an attractive cancer therapeutic target. However, successful of ta...

$6.47M
USD
Active NON-SBIR/STTR RPGS
Regulation of FLT3 Signaling in Leukemia
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2023 – 2028

Summary The temporal and spatial distribution of signaling proteins is dynamically regulated by post-translational modifications (PTMs). PTMs such as phosphorylation, ubiquitinatio...

$6.56M
USD
Active NON-SBIR/STTR RPGS
Cancer misinformation on social media and its correction
NATIONAL CANCER INSTITUTE Northeastern University United States 2023 – 2026

Project Summary The overarching goal of this study is to measure the prevalence of cancer misinformation on social media and understand the mechanisms that underlies its spread. Be...

$2.49M
USD
Completed OTHER RESEARCH-RELATED
2023 Annual Meeting of the American Society for Investigative Pathology
NATIONAL CANCER INSTITUTE American Society/Investigative Pathology United States 2023 – 2024

The 2023 Annual Meeting of the American Society for Investigative Pathology (ASIP), will be held in conjunction with the Tissue, Matrix, and Pathobiology conference from October 22...

$150K
USD
Completed OTHER RESEARCH-RELATED
Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2023 – 2024

PROJECT SUMMARY The African-Caribbean Cancer Consortium (AC3) is a Global Oncology Program at Fox Chase Cancer Center and plays a unique role by addressing cancer disparities invol...

$200K
USD
Active NON-SBIR/STTR RPGS
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Epstein Barr virus (EBV) is a broadly disseminated gammaherpes virus that, in immunosuppressed or immunocompromised individuals, can cause serious, life-th...

$6.28M
USD
Active NON-SBIR/STTR RPGS
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Abstract/Summary Among the Epstein-Barr virus associated cancers is post-transplant lymphoproliferative disease (PTLD), a rare but major complication of pediatric solid organ trans...

$9.87M
USD
Completed SBIR-STTR RPGS
An Inducible Swine Hepatocellular Carcinoma Platform for Enhanced Therapeutic Development
NATIONAL CANCER INSTITUTE Recombinetics, Inc United States 2023 – 2025

PROJECT SUMMARY Hepatocellular carcinoma (HCC) is a global health burden ranking as the fourth most common and second deadliest cancer in the world. Effective therapeutic strategie...

$3.42M
USD
Completed SBIR-STTR RPGS
VIPCare: Virtual Predictive Care workflow with integrated surveillance for optimal care protocol selection and management in at-risk prostate cancer patients
NATIONAL CANCER INSTITUTE Vizlitics Inc United States 2023 – 2024

Abstract Prostate cancer is the leading cancer diagnosis in men (not including skin cancer) and has high survival rates (98% at 5-years), resulting in an estimated 3.2M US men curr...

$4.07M
USD
Completed SBIR-STTR RPGS
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
NATIONAL CANCER INSTITUTE Briacell Therapeutics Corp United States 2023 – 2024

SUMMARY Cancer vaccines hold promise as immunotherapy due to strong and durable cancer-specific immune responses. Different types of cancer vaccines have been developed, including...

$4M
USD
Completed SBIR-STTR RPGS
Image-based risk assessment to identify women at high-risk for breast cancer
NATIONAL CANCER INSTITUTE Waved Medical Llc United States 2023 – 2025

7. PROJECT SUMMARY Breast cancer is the most common cancer worldwide and the most common cancer diagnosed in American women. While there has been good progress regarding detection...

$4.06M
USD
Completed SBIR-STTR RPGS
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
NATIONAL CANCER INSTITUTE Binary Genomics, Inc United States 2023 – 2025

ABSTRACT: Immunotherapies produce remarkable, long-term responses in subsets of patients with non-small cell lung cancer, but unfortunately, most patients do not respond to such tr...

$3.98M
USD
Completed SBIR-STTR RPGS
CD3 bispecific for the treatment of ROR2-positive NSCLC
NATIONAL CANCER INSTITUTE Traverse Biotech Ii Inc United States 2023 – 2024

Project Summary We are developing a novel CD3-bispecific antibody product, TB-Bs1, for the treatment of lung cancer. Lung cancer is the leading cause of cancer deaths in both men a...

$4M
USD
Completed SBIR-STTR RPGS
Antibody-guided localized activation of bioorthogonal protodrugs via click chemistry
NATIONAL CANCER INSTITUTE Shasqi, Inc United States 2023 – 2025

Abstract Shasqi is developing a platform to activate drugs at a specific site in the body, thus enhancing their efficacy while minimizing systemic toxicity and adverse drug events...

$7.82M
USD
Completed SBIR-STTR RPGS
Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients
NATIONAL CANCER INSTITUTE Up Therapeutics, Inc United States 2023 – 2025

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy despite aggressive surgery and toxic chemotherapies. More effective and safer targeted drugs are urgentl...

$8.68M
USD
Completed SBIR-STTR RPGS
Spatial genomics analysis of tumor samples
NATIONAL CANCER INSTITUTE Spatial Genomics, Inc United States 2023 – 2025

SUMMARY Imaging the tumor microenvironment (TME) is key to understanding tumor growth, disease progression and therapy options. The TME often consists of a complex neighborhood of...

$9.98M
USD
Completed OTHER RESEARCH-RELATED
Characterizing an alternatively spliced NTRK2 isoform in development and cancer
NATIONAL CANCER INSTITUTE Seattle Children'S Hospital United States 2023 – 2024

Project Summary/Abstract The link between developmental signaling and cancer initiation, maintenance and metastasis has long been known for several members of the Wnt, Hedgehog, an...

$756K
USD
Completed NON-SBIR/STTR RPGS
Molecular Biology and Genetics of Human Tumor Viruses
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2023 – 2024

PROJECT SUMMARY/ABSTRACT Viruses cause approximately 15% of human cancers. A viral etiology to a human cancer can have substantive consequences on its treatment and prevention. For...

$5M
USD
Active OTHER RESEARCH-RELATED
Improving the Generalizability of Deep Neural Networks by Teaching Single Nucleotide Polymorphisms Associated with LDCT Features
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2027

PROJECT SUMMARY Diagnostic and treatment approaches for non-small cell lung cancer (NSCLC) have evolved over the last decade from primarily empirical methodologies to objective str...

$972K
USD
Completed RESEARCH CENTERS
Experimental and preclinical modeling of NUP98-rearranged acute leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2025

Project Summary The overarching goals of the original FusOnC2 consortium award titled Experimental and Preclinical Modeling of NUP98-rearranged Acute Leukemia are to understand the...

$1.62M
USD